申请人:Bachmann Stephan
公开号:US20130059833A1
公开(公告)日:2013-03-07
The present invention relates to compounds of formula (I)
wherein R
1
, R
2
, R
3
, R
5
, W, X, X
1
, Y, Y
1
, Z and Z
1
are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit PDE10A and can be used in the treatment of CNS disorders such as schizophrenia, Alzheimer's disease, and Parkinson's disease.
本发明涉及式(I)的化合物,其中R1、R2、R3、R5、W、X、X1、Y、Y1、Z和Z1如描述和权利要求中定义,并且其生理上可接受的盐。这些化合物抑制PDE10A,可用于治疗中枢神经系统疾病,如精神分裂症、阿尔茨海默病和帕金森病。